Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3 trial of ...

Find out which IIT will offer the best average placement package in 2026. In our comprehensive 2025–2026 analysis, compare ...